ALKS
Alkermes plc
NASDAQ · IEHealthcareBiotechnology
$51.72-1.90%
Price as of Jul 20, 2026
ALKS capital
Alkermes plc capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.90x
- Net debt / equity
- 0.70x
- Debt / assets
- 0.37x
- Debt / EBITDA
- 5.72x
- Net debt / EBITDA
- 4.45x
Liquidity & coverage
- Current ratio
- 2.27x
- Quick ratio
- 1.70x
- Cash ratio
- 0.85x
- Interest coverage
- 5.79x
- EBITDA / interest
- 8.33x
- Working capital
- $759.1M
Cash & dividend
- FCF / debt
- 0.14x
- Cash flow / debt
- 0.16x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.